BDA creates visual dashboards designed to track company performance and aid customer interactions. Our dynamic, web-based reports help companies by tracking sales team KPIs, identifying trends, and conveying complex information in a visual and interactive manner that ease understanding for executives and customers alike.

Foresight Diagnostics is an early-stage, venture-backed molecular diagnostics company that is developing non-invasive cancer detection technologies to improve the lives of patients worldwide. Our portfolio of cell-free DNA based liquid biopsy tests are rooted in novel and proprietary methods developed at Stanford University. Our approach enables the earlier detection of smaller tumors, leading to more personalized and effective cancer treatment strategies for patients. We have deep expertise in molecular biology, bioinformatics, and Next Generation Sequencing (NGS), and maintain a dynamic, fast-paced work environment with significant opportunities for high-impact contribution and rapid professional growth. Foresight Diagnostics is headquartered in Aurora, Colorado.

Genomenon is a genomic health IT company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases and cancer.

Product Owner for the core components of the company’s flagship product, ESP (Enterprise Science Platform). Founded in 2011, L7's Enterprise Science Platform reimagines data intelligence for modern life sciences and healthcare organizations by optimizing the flow of information between process and people, unlocking innovation at every stage of the clinical, research, and manufacturing value chains.

Software leader for the Genomics organization within Q2 Solutions.Launched in 2015, Q2 Solutions is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights.

Bioinformatics leader responsible for all activities related to the development of Genomind’s Precision Behavioral Healthcare Technology Platform and product portfolio, both commercially and in research. Genomind is a personalized medicine company bringing innovation to mental healthcare through genetic testing.

Member of the leadership team for Beckman Coulter's Genomic Services business unit and senior leader of the Bioinformatics, Software, IT, and Client Services teams. Beckman Coulter Genomics was a services business that delivers expert genomics solutions to life science and healthcare businesses as well as academic and government institutions worldwide. Beckman Coulter Genomics was sold to Genewiz in February, 2016.

Software team leader responsible for product development and the creation of quality control and product support teams. Led the software effort for the interpretation services division focusing on cost and productivity optimization. Knome was a bioinformatics start-up focused on human whole genome variant analysis and interpretation. Knome was sold to Tute Genomics in November, 2015.

Senior technology leader focused on the development and support of E-NOTEBOOK, the company’s 40 million dollar per year flagship product. CambridgeSoft was a scientific software company focused on cheminformatics and electronic laboratory notebooks. CambridgeSoft was sold to PerkinElmer in March, 2011.

Consultant responsible for ensuring continuing operations of off-the-shelf software, performing installations, applying and testing enhancements, patches and upgrade to applications.

Leader of the laboratory automation software engineering group at Caliper Life Sciences. Caliper Life Sciences, formerly Zymark, was a laboratory robotics company best known for their SciClone liquid handler and Twister II plate handler. Caliper Life Sciences was acquired by PerkinElmer in September, 2011.

Team software engineering leader involved in the creation of software to software to track, manage, and analyze high volume scientific information in support of drug target identification and sequencing. Genome Therapeutics was a biotech best known for sequencing the first commercial genome (Helicobacter pylori, the pathogen responsible for peptic ulcers). Genome Therapeutics changed its name to Oscient Pharmaceuticals and its sequencing division joined with Agencourt Bioscience in April, 2004.

Member of the staff supporting the Mouse Genome Database through the review of scientific journal articles, validation of reported scientific data, preparation of scientific data for database entry, and advising on screen layouts and forms during Mouse Genome Database development. The Jackson Laboratory is an independent nonprofit organization leveraging eight decades of expertise in genetics and genomics to increase understanding of human disease and discover precise genomic solutions.